Introduction
Over the last 10 years, the diagnostic and management needs of infants and young children admitted to the specialist malaria referral unit at Queen Elizabeth Hospital, Blantyre, Malawi, have been systematically refined and codified. This has led to the development of effective and efficient protocols for use in peripheral hospitals with minimal laboratory facilities (1) . These have been validated in district hospitals in Malawi and are in general use, with mortality outcomes similar to those achieved in the specialist malaria unit (2) .
However, the majority of infants and young children in Malawi and similar countries are not within reach of a hospital when they become severely ill (3) , and 65 % rely for all their health care on rural health centres that are minimally equipped for emergency situations and have no laboratory facilities. In Malawi, each rural health centre caters for 20000-30000 people, at least 20% of whom live more than 8km from a given centre. Each health centre is run by a medical assistant with 3 years' postprimary school training, who supervises the various cadres of more junior staff. Few centres have regular access to motor transport and fewer again have telephones and electricity; furthermore, it is not unusual for many of these services to be cut off for days and weeks during the rainy season (December-April).
Preliminary estimates, together with an informal review of local hospital and health centre records, suggest that case fatality from severe/cerebral malaria can be reduced to 18-20% in a special unit (1) and to 22% if protocols are followed for children presenting at a district general hospital (2) . However, at the health centre level, estimates from the preliminary phase of the present study show that the fatality rate is nearer 50%. The reasons for this are as follows:
-frequent critical lack of drugs, especially quinine; -inability to correct severe hypoglycaemia, which is of high prognostic value to the outcome of cerebral malaria (1); -frequent impossibility of timely referral to hospital; and -inability of the medical assistant at the health centre level to distinguish between severe malaria and meningitis. The present study was designed to overcome these difficulties, without major extra resources, and to test the hypothesis that a significant lowering of mortality could be achieved by providing emergency "packaged" treatment at the health centre level.
The study was carried out in the Mangochi District in southern Malawi, an area of high endemicity 
Methods
The study design compared case fatality during a 6-month pre-trial period of normal practice care with that during a 6-month trial period of "packaged care". Ideally, a randomized control trial of different health centres would have been carried out, but this could not be conducted blind and there were too many variables, including opportunities for hospital referral, to make matching possible.
During the pre-trial period (July to December 1995) medical assistants in 10 health centres were asked to record all cases with a presumptive diagnosis of severe/cerebral malaria or meningitis, follow normal protocols of management, and record outcomes or referrals to hospital according to Malawi Standard treatment guidelines (5) .a The treatment recommended at health centre level for a child unable to swallow is administration of intramuscular quinine (10mg/kg body weight), repeated after 4 hours if referral has not been achieved, and of oral sulfadoxine (500mg) + pyrimethamine (25mg) if the child can take oral therapy. For presumptive bacterial meningitis, an intramuscular injection of benzylpenicillin (50000 units/kg) followed by immediate transfer is recommended. However, during the trial period in the 10 sentinel health centres, quinine was sometimes unavailable and benzylpenicillin almost invariably unavailable.
The trial period encompassed the malaria season from January to June 1996. Medical assistants in all 24 health centres in Mangochi District were invited to take part and after 2 days of training and discussion, 22 agreed to do so (Fig. 1) The safety of intramuscular quinine, even when given to an unconscious child, has been demonstrated in several studies (6) . For the present study, 1 ml from an ampoule containing 600mg of quinine hydrochloride in 2 ml solution was diluted in 5 ml sterile water for injection (equivalent to 0.2mtkg or 10mg/kg body weight). The inclusion of chloramphenicol as first-line treatment for meningitis is in accordance with current practice in the paediatric department at Queen Elizabeth Hospital, Blantyre; dextrose was used as a substitute for powdered glucose, which was unobtainable in Malawi at the time. Hypoglycaemia is a strong predictor of mortality in cerebral malaria (7) and the assumption was made that it could be corrected without measuring blood glucose levels. The dosage schedules stipulated in the protocol and included in the nomogram were as follows:
-rehydration using oral rehydration salt (ORS) solution, if necessary by nasogastric tube; -intramuscular quinine (0.2 ml/kg weight) repeated every 4 hours as necessary; -chloramphenicol (25 mg/kg weight stat.); -paraldehyde (0.2 ml/kg weight) (deep intramuscular), repeated if necessary; and -dextrose (10ml drawn from 20-ml vial) mixed with 10ml of clean water in a cup and spooned or injected down the nasogastric tube.
Packs were only opened upon arrival of a defined case, and any unused materials were never re-used on a second case. Packs were supplied as needed during the trial.
If the children were referred to hospital, copies of the records from the rural health centre accompanied them and were retrieved from hospital records by the investigators. The single outcome measure in both phases of the study was infant survival. Survival was assumed if the infant or child was discharged from the health centre or hospital as "well" or "cured" or was lost to follow-up in a state recorded on the chart as "better", "improved", "cured", "well", etc. Similarly, death was assumed if the infant or child was lost to followup or was categorized as "not improved", "ill", "worse", etc. A simple access score, applicable to the period of the trial, was assessed to indicate the overall possibility of referral from each health centre in the event of serious illness (see Table 2 ). It had been planned to visit each health centre at least twice during the trial phase, but this proved impossible because of the extraordinarily heavy rains, impassable roads, and broken bridges. However, each health centre was visited in May, at which time problems were discussed and the record forms collected.
Results
During the pre-trial phase (July-December 1995), records for 64 infants and children under the age of 6 years were retrieved from the 10 health centres used as sentinel sites for the study ( Omissions largely arose because one or two key medical assistants were posted elsewhere during the trial, leaving a more junior staff member unfamiliar with the protocol in charge. However, there was also a tendency to rely on instinct when diagnosing and giving treatment, and so save drugs. Another factor was the dislike of the mothers for nasogastric tubes, which they associated with death. In this way, several children did not receive dextrose dosages. None the less, there was no obvious association between any omission and mortality. Fig. 1 ).
c Scored as follows: adequate all-weather road, Jan.-June = 1; telephone to district general hospital = 1; transport available on site = 1.
In the pre-trial phase, 19 (30%) of the 64 infants and children seen were lost to follow-up ( Table 3 ), signifying that referral to hospital was recorded but no trace of admission could be found in local hospital records. It is probable that many of these infants either died en route, or were taken to a local healer; however, calculations of case fatality were based only on the 45 for whom outcome data were available could be strongly presumed. During the trial phase, more successful methods were used to trace referred children, and only 3 (3 %) of the 96 were lost to follow-up. Therefore, 93 was used as a basis for the trial phase, and the overall case fatality consequently fell from 51% in the pre-trial phase to 23% in the trial phase.
The greatest reduction in the number of case fatalities -from 17 of 33 children in the pre-trial phase to 1 out of 30 children (3%) in the trial phase -occurred among those for whom no referral was either planned or achieved (see Table 3 ). Many factors influenced a decision to refer, but one of the strongest, which separated the trial from the pre-trial phase, was the medical assistants' confidence in being able to achieve results locally if immediate referral was not possible. Until the time of the trial phase, transfer from the health centre was the accepted goal of successful management, whatever the condition of the child or treatment achieved. The medical assistant seldom learned the outcome following referral or even whether the child had arrived in the hospital. The apparent increase in fatality among those for whom referral was arranged but not achieved (Table 3 ) may be because of much better case detection during the trial phase.
Of the 32 children who did arrive in hospital (Table 3) , 2 died and 30 recovered. In 17 cases (53%) the child was diagnosed and treated for severe or cerebral malaria, in 4 cases (13%) for meningitis, and in 3 cases (10%) for malaria and meningitis; in only one case of meningitis was a lumbar puncture performed. Two more children were treated for malaria together with severe anaemia, two for malaria and pneumonia, and in one case the diagnosis remained uncertain. These diagnoses, leading in all but two cases to complete recovery, were undoubtedly influenced by the primary diagnosis and management at the health centres.
During both the pre-trial and trial phases, deaths occurred throughout the age range 0-6 years. Most children died while awaiting transport to hospital, although in the pre-trial phase, mortality was also high among the nine children who arrived at a hospital (see Table 3 ). During the trial phase, 29% of children who died or were presumed to have died, did so within an hour of presenting to the health centre, with this proportion rising to 48% within 3 hours of presenting. Since less than one-third (31%) of the referrals requested could be initiated within 3 hours, even the speediest was irrelevant for the eventual outcome of a third of the children. A further No detailed analyses of the reasons for referral versus health centre management can be made, since they depend on too many interactive factors, including parental fears and wishes, clinical condition, transport availability, access problems and medical assistants' recent experiences. Although coma scores at presentation in the health centre are a fairly good predictor of infant death (case fatality rate = 63%, 22%, 11%, respectively, for children with a coma score of 0, 1, and 2 (Table 4) ), it did not seem to influence the decision to refer. Thus, children with coma scores of 0-1 were not significantly more likely to be referred than those with a coma score of 2. A total of 57% of children presented to a health centre where referral access was difficult or very difficult (access scores of score 0 or 1) and less than half (46%) of the 39 planned referrals were eventually achieved (Table 5 ). Where access was easier (scores of 2 or 3), only 15% of the 27 planned referrals were unsuccessful. Although a low coma score identified children at particular risk of dying (Table 4) , and access ( Despite these problems, children staying in the health centres appeared to do as well as those referred to hospital, even though no more than 63% were recorded as receiving the full treatment agreed to in the study protocol.
Estimating the costs and benefits of providing packaged treatment at remote health centres is not easy because discounting against the costs of referral, which so often depends on the chance availabilb There is some evidence that single-dose chloramphenicol is as effective as 5 days of antibiotics in the treatment of meningococcal meningitis (8) but it is not the accepted treatment in Malawi (4). ity of vehicles, is hazardous. Including the US $6 for the emergency pack, the estimated cost of each life saved was US$ 29. This seems low by standards in developed countries, but compared to the annual expenditure of approximately US$ 2.50 per capita for all health care in Malawi, over two-thirds of which comes from external sources, it is high. On the other hand, transfer to hospital using a hospital-based ambulance, which costs approximately US$ 0.30perkm on average, corresponds to not less than US$ 30 per transfer.
Conclusions
A marked drop in the mortality of infants and children presenting with signs and symptoms indicative of acute/cerebral malaria or meningitis can be achieved by preparing packs containing items necessary for emergency treatment and making them available at the first point of contact with the health service. However, further controlled studies are needed to determine whether these packs can be routinely used at the periphery.
Resume
Trousses pretes a 1'emploi pour le traitement d'urgence du neuropaludisme et de la meningite Cet article decrit les resultats d'un essai realis6 de janvier a juin 1996 dans le sud du Malawi pour d6terminer l'efficacit6 d'une trousse prete a l'emploi pour le traitement des nourrissons et des enfants de moins de six ans conduits en urgence dans les centres de sant6 ruraux avec un diagnostic pr6somptif de paludisme grave/neuropaludisme ou de m6ningite. Chaque trousse (coOt approximatif: USD 6) contient le necessaire pour un traitement complet: quinine pour voie intramusculaire, chloramph6nicol pour voie intramusculaire, dextrose, parald6hyde, une sonde nasogastrique, des seringues pr6emballees et de l'eau sterile. Elle contient 6galement une 6chelle modifiee de profondeur du coma et un nomogramme posologique.
11 est possible d'obtenir une baisse sensible de la mortalit6 des nourrissons et des enfants pr6sentant des signes et symptomes evocateurs de paludisme grave/neuropaludisme ou de meningite en preparant des trousses contenant tout le necessaire pour le traitement d'urgence et en mettant ces trousses a la disposition des premiers points de contact avec les services de sante. Cependant, des 6tudes contr6l6es sont n6cessaires pour d6terminer si de telles trousses peuvent etre utilis6es en routine au niveau p6riph6rique.
